林平,王旖旎,高学琴,赵振娟

• 1:哈尔滨医科大学护理学院
• 2:哈尔滨医科大学附属第二医院心内科

摘要(Abstract)：

<正>目前,冠状动脉支架置入术由于创伤小、恢复快、安全性高等优点,已经成为治疗冠心病的重要手段,但术后支架内再狭窄的发生仍是影响患者预后不可忽视的因素~([1-2])。随着冠状动脉内影像学技术的发展,有研究发现冠状动脉支架术后内膜异质性的发生可能是引起支架内再狭窄的不利因素~([3-4]),目前内膜异质性现象逐渐受到研究者的重视。1内膜异质性概述支架内新生内膜形成是一个损伤修复的过程,由于支架

关键词(KeyWords)： 光学相干断层成像;内膜异质性;支架内再狭窄

Abstract:

Keywords:

基金项目(Foundation): 黑龙江省自然科学资金(D201180)

作者(Author): 林平,王旖旎,高学琴,赵振娟

参考文献(References)：

• [1]Mauri L,Silbaugh TS,Wolf RE,et al.Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts.Circulation,2008,118:1817-1827.
• [2]Lee JY,Park DW,Kim YH,et al.Incidence,predictors,treatment,and long-term prognosis of patients with restenosis after drug-eluting stent implantation for unprotected left main coronary artery disease.J Am Coll cardiol,2011,57:1349-1358.
• [3]Gonzalo N,Serruys PW,Okamura T,et al.Optical coherence tomography patterns of stent restenosis.Am Heart J,2009,158:284-293.
• [4]Kaneda H,Ako J,Kataoka T,et al.Heterogeneity of neointimal distribution of in-stent restenosis in patients with diabetes mellitus.Am J Cardiol,2006,97:340-342.
• [5]Hoffmann R,Mintz GS,Dussaillant GR,et al.Patterns and mechanisms of in-stent restenosis.A serial intravascular ultrasound study.Circulation,1996,94:1247-1254.
• [6]Finn AV,Joner M,Nakazawa G,et al.Pathological correlates of late drug-eluting stent thrombosis;strut coverage as a marker of endothelialization.Circulation,2007,115:2435-2441.
• [7]Hou J,Jia H,Liu H,et al.Neointimal tissue characteristics following sirolimus-eluting stent implantation;OCT quantitative tissue property analysis.Int J Cardiovasc Imaging,2012,28;1879-1886.
• [8]Takano M,Yamamoto M,Inami S,et al.Appearance of lipidladen intima and neovascularization after implantation of baremetal stents extended late-phase observation by intracoronary optical coherence tomography.J Am Coll Cardiol,2009,55;26-32.
• [9]Hou J,Qi H,Zhang M,et al.Development of lipid-rich plaque inside bare metal stent;possible mechanism of late stent thrombosis?An optical coherence tomography study.Heart,2010,96:1187-1190.
• [10]Ishibashi F,Aziz K,Abela GS,et al.Update on coronary angioscopy:review of a 20-year experience and potential application for detection of vulnerable plaque.J Interv Cardiol,2006,19:17-25.
• [11]Higo T,Ueda Y,Oyabu J,et al.Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent;an angioscopic study.JACC Cardiovasc Imaging,2009,2;616-624.
• [12]Hara M,Nishino M,Taniike M,et al.High incidence of thrombus formation at 18 months after paclitaxel-eluting stent implantation:angioscopic comparison with sirolimus-eluting stent.Am Heart J,2010,159:905-910.
• [13]Liebson PR,Klein LW.Intravascular ultrasound in coronary atherosclerosis;a new approach to clinical assessment.Am Heart J,1992,123:1643-1660.
• [14]Colombo A,Hall P,Nakamura S,et al.Intracoronary stenting with out anticoagulation accomplished With intravascular ultrasound guidance.Circulation,1995,91:1678-1688.
• [15]Costa Jde R Jr,Mintz GS,Carlier SG,et al.Frequency and determinants of black holes in sirolimus-eluting stent restenosis.J Invasive Cardiol,2006,18:348-352.
• [16]Costa MA,Sabate M,Angiolillo DJ,et al.Intravascular ultrasound characterization of the"black hole"phenomenon after drug-eluting stent implantation.Am J Cardiol,2006,97:203-206.
• [17]Shiratori Y,Oikawa Y,Yajima J."Black hole"restenosis after sirolimus-eluting stent Implantation.J Invasive Cardiol,2008,20:E253-E255.
• [18]Bouma BE,Teamey GJ,Yabushita H,et al.Evaluation of intracoronary stenting by intravascular optical coherence tomography.Heart,2003,89:317-320.
• [19]De Smet BJ.Zijlstra F.A look at drug eluting stents with optical coherence tomography.Eur Heart J,2007,28:918-919.
• [20]何强,夏大胜,赵向东,等.经皮冠状动脉介入治疗后支架边缘夹层的光学相干断层成像评价.中国介入心脏病学杂志,2014,22:4043.
• [21]Meng L,Lv B,Zhang S,et al.In vivo optical coherence tomography of experimental thrombosis in a rabbit carotid model.Heart,2008,94:777-780.
• [22]Kim JS,Fan C,Choi D,et al.Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation:9-month followup optical coherence tomography study.Int J Cardiol,2011,146:341-346.
• [23]Kume T,Akasaka T,Kawamoto T,et al.Visualization of neointima formation by optical coherence tomography.Int Heart J,2005,46:1133-1136.
• [24]Hara M,Nishino M,Taniike M,et al.Difference of neointimal formational partem and incidence of thrombus formation among 3kinds of stents:an angioscopic study.JACC Cardiovasc Interv,2010,3:215-220.
• [25]Ino Y,Kubo T,Kitabata H,et al.Difference in neointimal appearance between early and late restenosis after sirolimuseluting stent implantation assessed by optical coherence tomography.Coron Artery Dis,2013,24:95-101.
• [26]Kim JS,Kim TH,Fan C,et al.Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation.Circ J,2010,74:320-326.
• [27]Kim JS,Lee JH,Shin DH,et al.Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drugeluting stent implantation.JACC Cardiovasc Imaging,2014,7:788-795.